Urinary Tract Infection Testing Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2024-2031
Persistence Market Research는 최근 세계 요로감염(UTI) 검사 시장에 대한 종합적인 보고서를 발표했습니다. 이 보고서는 촉진요인, 동향, 기회 및 과제를 포함한 주요 시장 역학을 철저히 평가하고 시장 구조에 대한 심층적인 통찰력을 제공합니다.
주요 인사이트
- 요로감염 검사 시장 규모(2024년) : 6억3,450만 달러
- 시장 예측 금액(2031년) : 9억 6,030만 달러
- 세계 시장 성장률(2024-2031년 CAGR) : 6.1%.
요로감염 검사 시장 - 조사 범위:
요로감염 검사에는 소변 검사, 소변 배양, 중합효소연쇄반응(PCR), 신속 딥스틱 검사 등 요로감염증을 유발하는 병원균의 존재를 검출하기 위한 다양한 진단 방법이 포함됩니다. 이 시장은 병원, 클리닉, 진단 실험실, 재택치료 현장을 대상으로 현장 진료 검사 키트, 실험실 기반 분석 등 다양한 검사 유형을 제공합니다. 시장 성장의 원동력은 요로결석 유병률 증가, 조기 진단에 대한 인식 증가, 진단 기술의 발전으로 인한 검사 정확도 향상 및 환자 결과 개선입니다.
시장 성장의 촉진요인:
세계 요로감염 검사 시장은 특히 여성, 노인, 만성질환자 사이에서 요로감염 발병률이 증가하는 등 몇 가지 중요한 요인에 의해 주도되고 있습니다. 요로결석의 조기 진단과 치료의 중요성에 대한 인식이 높아지면서 시장 확대가 더욱 가속화되고 있습니다. 신속하고 민감한 진단 검사의 개발 등 기술 발전으로 정확도가 향상되고 결과가 빨라지면서 시장 성장을 가속하고 있습니다. 또한, 현장 검사 및 재택 진단 서비스의 확대는 시장 참여자들이 더 많은 환자 집단에 접근할 수 있는 새로운 경로를 창출하고 있습니다.
시장 성장 억제요인 :
유망한 성장 전망에도 불구하고 요로감염 검사 시장은 규제 준수, 상환 정책, 고급 진단 검사의 높은 비용 등의 문제에 직면해 있습니다. 진단 기기의 제조, 판매 및 사용에 대한 엄격한 규제는 제조업체와 의료 서비스 제공업체에게 규정 준수에 대한 부담을 가중시켜 시장 진입 장벽과 운영 비용에 영향을 미치고 있습니다. 또한 요로결석 진단 검사에 대한 제한적인 보험급여 범위와 고가의 고가 장비는 특히 의료 예산이 부족한 신흥국에서 시장 침투에 어려움을 겪고 있습니다. 이러한 규제와 경제적 장벽을 극복하기 위해서는 업계 이해관계자와 정책 입안자들이 협력하여 저렴하고 신뢰할 수 있는 요로감염 검사 솔루션에 대한 접근성을 높여야 합니다.
시장 기회 :
요로감염 검사 시장은 기술 혁신, 인구 동향, 진화하는 의료 서비스 제공 모델로 인해 큰 성장 기회를 맞이하고 있습니다. 원격 모니터링 및 원격 의료 플랫폼과 같은 디지털 헬스 기술의 통합은 진단 서비스에 대한 환자의 접근성을 향상시키고 치료 순응도와 결과를 개선할 수 있습니다. 또한, 분자진단의 적용 확대와 여러 병원체를 동시에 검출하는 멀티플렉스 분석 시장 개척은 시장 범위를 넓히고 기술 혁신을 촉진할 것입니다. 전략적 파트너십, R&D 투자, 사용자 친화적이고 비용 효율적인 진단 솔루션의 도입은 새로운 기회를 활용하고 역동적인 요로감염 검사 시장에서 리더십을 유지하는 데 필수적입니다.
본 보고서에서 다룬 주요 질문들
- 세계 요로감염 검사 시장의 성장을 가속하는 주요 요인은?
- 다양한 의료 환경에서 어떤 검사 유형과 용도가 UTI 검사의 채택을 촉진하고 있는가?
- 기술의 발전은 요로감염 검사 시장 경쟁 구도를 어떻게 변화시키고 있는가?
- 요로감염 검사 시장에 기여하고 있는 주요 기업은 어디이며, 시장 관련성을 유지하기 위해 어떤 전략을 취하고 있는가?
- 세계 요로감염 검사 시장의 새로운 트렌드와 전망은?
목차
제1장 주요 요약
제2장 시장 개요
- 시장 범위와 정의
- 시장 역학
- 성장 촉진요인
- 성장 억제요인
- 기회
- 과제
- 주요 동향
- 검사 수명주기 분석
- 세계의 요로감염 검사 시장 : 밸류체인
- 검사 키트 공급업체 리스트
- 제조업체 리스트
- 유통업체 리스트
- 용도 리스트
- 수익성 분석
- Porter’s Five Forces 분석
- 지정학적 긴장 : 시장에 대한 영향
- 거시경제 요인
- 세계의 부문별 전망
- 세계의 GDP 성장 전망
- 세계의 상위 시장 개요
- 예측 요인 - 관련성과 영향
- 규제와 검사 키트 상황
제3장 세계의 요로감염 검사 시장 전망 : 실적(2019년-2023년)과 예측(2024년-2031년)
- 주요 하이라이트
- 시장 수량(유닛) 예측
- 시장 규모와 전년대비 성장률
- 절대액 기회
- 시장 규모(백만 달러) 분석과 예측
- 과거 시장 규모 분석, 2019년-2023년
- 현재 시장 규모 예측, 2024년-2031년
- 세계의 요로감염 검사 시장 전망 : 검사
- 서론/주요 조사 결과
- 과거 시장 규모(백만 달러)와 수량(유닛) 분석 : 검사별, 2019년-2023년
- 현재 시장 규모(백만 달러)와 수량(유닛) 예측 : 검사별, 2024년-2031년
- 시장의 매력 분석 : 검사
- 세계의 요로감염 검사 시장 전망 : 검사 키트
- 서론/주요 조사 결과
- 과거 시장 규모(백만 달러)와 수량(유닛) 분석 : 검사 키트별, 2019년-2023년
- 현재 시장 규모(백만 달러)와 수량(유닛) 예측 : 검사 키트별, 2024년-2031년
- 시장의 매력 분석 : 검사 키트
- 세계의 요로감염 검사 시장 전망 : 적응증
- 서론/주요 조사 결과
- 과거 시장 규모(백만 달러)와 수량(유닛) 분석 : 적응증별, 2019년-2023년
- 현재 시장 규모(백만 달러)와 수량(유닛) 예측 : 적응증별, 2024년-2031년
- 시장의 매력 분석 : 지표
- 세계의 요로감염 검사 시장 전망 : 최종 용도
- 서론/주요 조사 결과
- 과거 시장 규모(백만 달러)와 수량(유닛) 분석 : 최종 용도별, 2019년-2023년
- 현재 시장 규모(백만 달러)와 수량(유닛) 예측 : 최종 용도별, 2024년-2031년
- 시장의 매력 분석 : 최종 용도
제4장 세계의 요로감염 검사 시장 전망 : 지역
- 주요 하이라이트
- 과거 시장 규모(백만 달러)와 수량(유닛) 분석 : 지역별, 2019년-2023년
- 현재 시장 규모(백만 달러)와 수량(유닛) 예측 : 지역별, 2024년-2031년
- 북미
- 유럽
- 동아시아
- 남아시아·오세아니아
- 라틴아메리카
- 중동 및 아프리카(MEA)
- 시장의 매력 분석 : 지역
제5장 북미의 요로감염 검사 시장 전망 : 실적(2019년-2023년)과 예측(2024년-2031년)
제6장 유럽의 요로감염 검사 시장 전망 : 실적(2019년-2023년)과 예측(2024년-2031년)
제7장 동아시아의 요로감염 검사 시장 전망 : 실적(2019년-2023년)과 예측(2024년-2031년)
제8장 남아시아·오세아니아의 요로감염 검사 시장 전망 : 실적(2019년-2023년)과 예측(2024년-2031년)
제9장 라틴아메리카의 요로감염 검사 시장 전망 : 실적(2019년-2023년)과 예측(2024년-2031년)
제10장 중동 및 아프리카의 요로감염 검사 시장 전망 : 실적(2019년-2023년)과 예측(2024년-2031년)
제11장 경쟁 구도
- 시장 점유율 분석, 2024년
- 시장 구조
- 경쟁 강도 매핑 : 시장별
- 경쟁 대시보드
- 보이는 검사 능력
- 기업 개요(상세 - 개요, 재무, 전략, 최근 동향)
- ACON Laboratories Inc.
- Cardinal Health Inc.
- Danaher Corporation
- SYSMEX CORPORATION
- Abbott Laboratories
- Bio-Rad Laboratories
- Roche AG
- LabCorp(Laboratory Corporation of America Holdings).
- Stryker Corporation
- Thermo Fisher Scientific, Inc.
제12장 부록
LSH
Persistence Market Research has recently released a comprehensive report on the worldwide market for urinary tract infection (UTI) testing. The report offers a thorough assessment of crucial market dynamics, including drivers, trends, opportunities, and challenges, providing detailed insights into the market structure.
Key Insights:
- UTI Testing Market Size (2024E): USD 634.5 Mn
- Projected Market Value (2031F): USD 960.3 Mn
- Global Market Growth Rate (CAGR 2024 to 2031): 6.1%
UTI Testing Market - Report Scope:
Urinary tract infection testing encompasses a variety of diagnostic methods, including urinalysis, urine culture, polymerase chain reaction (PCR), and rapid dipstick tests, to detect the presence of pathogens causing UTIs. The market caters to hospitals, clinics, diagnostic laboratories, and homecare settings, offering a range of test types, including point-of-care testing kits and laboratory-based assays. Market growth is driven by the increasing prevalence of UTIs, rising awareness about early diagnosis, and advancements in diagnostic technologies, enhancing test accuracy and patient outcomes.
Market Growth Drivers:
The global UTI testing market is propelled by several key factors, including the growing incidence of urinary tract infections, particularly among women, the elderly, and individuals with chronic conditions. Rising awareness about the importance of early diagnosis and treatment of UTIs further drives market expansion. Technological advancements, such as the development of rapid and highly sensitive diagnostic tests, offer improved accuracy and quicker results, fostering market growth. Moreover, the increasing adoption of point-of-care testing and the expansion of home-based diagnostic services create new avenues for market players to reach a wider patient population.
Market Restraints:
Despite promising growth prospects, the UTI testing market faces challenges related to regulatory compliance, reimbursement policies, and the high cost of advanced diagnostic tests. Stringent regulations governing the manufacturing, marketing, and use of diagnostic devices impose compliance burdens on manufacturers and healthcare providers, affecting market entry barriers and operational costs. Furthermore, limited reimbursement coverage for UTI diagnostic tests and the high cost of advanced testing equipment pose challenges for market penetration, particularly in emerging economies with constrained healthcare budgets. Addressing these regulatory and economic barriers requires collaboration between industry stakeholders and policymakers to promote access to affordable and reliable UTI testing solutions.
Market Opportunities:
The UTI testing market presents significant growth opportunities driven by technological innovations, demographic trends, and evolving healthcare delivery models. The integration of digital health technologies, such as remote monitoring and telemedicine platforms, enhances patient access to diagnostic services and improves treatment adherence and outcomes. Furthermore, the expanding application of molecular diagnostics and the development of multiplex assays for simultaneous detection of multiple pathogens broaden the market scope and stimulate innovation. Strategic partnerships, investment in research and development, and the introduction of user-friendly, cost-effective diagnostic solutions are essential to capitalize on emerging opportunities and sustain market leadership in the dynamic UTI testing landscape.
Key Questions Answered in the Report:
- What are the primary factors driving the growth of the UTI testing market globally?
- Which test types and applications are driving UTI testing adoption across different healthcare settings?
- How are technological advancements reshaping the competitive landscape of the UTI testing market?
- Who are the key players contributing to the UTI testing market, and what strategies are they employing to maintain market relevance?
- What are the emerging trends and future prospects in the global UTI testing market?
Competitive Intelligence and Business Strategy:
Leading players in the global UTI testing market, including Siemens Healthineers, Abbott Laboratories, and Becton, Dickinson and Company (BD), focus on innovation, product differentiation, and strategic partnerships to gain a competitive edge. These companies invest in R&D to develop advanced diagnostic solutions, including molecular tests and rapid testing kits, catering to diverse patient needs and clinical requirements. Collaborations with healthcare providers, diagnostic laboratories, and regulatory agencies facilitate market access and promote technology adoption. Moreover, emphasis on clinical research, evidence-based practice, and patient education fosters market growth and enhances patient outcomes in the rapidly evolving UTI testing landscape.
Key Companies Profiled:
- ACON Laboratories Inc.
- Cardinal Health Inc.
- Danaher Corporation
- SYSMEX CORPORATION
- Abbott Laboratories
- Bio-Rad Laboratories
- Roche AG
- LabCorp (Laboratory Corporation of America Holdings).
- Stryker Corporation
- Thermo Fisher Scientific, Inc.
Urinary Tract Infection Testing Market Research Segmentation
By Tests:
- Urinalysis
- Urine Cultures
- Susceptibility Testing
By Tests Kits:
- Home Test Kits
- Laboratory Test Kits
By Indication:
- Cystitis
- Urethritis
- Pyelonephritis
By End User:
- Hospitals
- Nephropathy Clinics
- Diagnostic Laboratories
By Region:
- North America
- Europe
- East Asia
- South Asia & Oceania
- Latin America
- Middle East & Africa
Table of Contents
1. Executive Summary
- 1.1. Global Urinary Tract Infection Testing Market Snapshot, 2024-2031
- 1.2. Market Opportunity Assessment, 2024-2031, US$ Mn
- 1.3. Key Market Trends
- 1.4. Future Market Projections
- 1.5. Premium Market Insights
- 1.6. Industry Developments and Key Market Events
- 1.7. PMR Analysis and Recommendations
2. Market Overview
- 2.1. Market Scope and Definition
- 2.2. Market Dynamics
- 2.2.1. Drivers
- 2.2.2. Restraints
- 2.2.3. Opportunity
- 2.2.4. Challenges
- 2.2.5. Key Trends
- 2.3. Tests Lifecycle Analysis
- 2.4. Global Urinary Tract Infection Testing Market: Value Chain
- 2.4.1. List of Tests Kits Supplier
- 2.4.2. List of Manufacturers
- 2.4.3. List of Distributors
- 2.4.4. List of Applications
- 2.4.5. Profitability Analysis
- 2.5. Porter Five Force's Analysis
- 2.6. Geopolitical Tensions: Market Impact
- 2.7. Macro-Economic Factors
- 2.7.1. Global Sectorial Outlook
- 2.7.2. Global GDP Growth Outlook
- 2.7.3. Global Parent Market Overview
- 2.8. Forecast Factors - Relevance and Impact
- 2.9. Regulatory and Tests Kits Landscape
3. Global Urinary Tract Infection Testing Market Outlook: Historical (2019-2023) and Forecast (2024-2031)
- 3.1. Key Highlights
- 3.1.1. Market Volume (Units) Projections
- 3.1.2. Market Size and Y-o-Y Growth
- 3.1.3. Absolute $ Opportunity
- 3.2. Market Size (US$ Mn ) Analysis and Forecast
- 3.2.1. Historical Market Size Analysis, 2019-2023
- 3.2.2. Current Market Size Forecast, 2024-2031
- 3.3. Global Urinary Tract Infection Testing Market Outlook: Tests
- 3.3.1. Introduction / Key Findings
- 3.3.2. Historical Market Size (US$ Mn ) and Volume (Units) Analysis By Tests, 2019-2023
- 3.3.3. Current Market Size (US$ Mn ) and Volume (Units) Forecast By Tests, 2024-2031
- 3.3.3.1. Urinalysis
- 3.3.3.2. Urine Cultures
- 3.3.3.3. Susceptibility Testing
- 3.4. Market Attractiveness Analysis: Tests
- 3.5. Global Urinary Tract Infection Testing Market Outlook: Tests Kits
- 3.5.1. Introduction / Key Findings
- 3.5.2. Historical Market Size (US$ Mn ) and Volume (Units) Analysis By Tests Kits, 2019-2023
- 3.5.3. Current Market Size (US$ Mn ) and Volume (Units) Forecast By Tests Kits, 2024-2031
- 3.5.3.1. Home Test Kits
- 3.5.3.2. Laboratory Test Kits
- 3.6. Market Attractiveness Analysis: Tests Kits
- 3.7. Global Urinary Tract Infection Testing Market Outlook: Indication
- 3.7.1. Introduction / Key Findings
- 3.7.2. Historical Market Size (US$ Mn ) and Volume (Units) Analysis By Indication, 2019-2023
- 3.7.3. Current Market Size (US$ Mn ) and Volume (Units) Forecast By Indication, 2024-2031
- 3.7.3.1. Cystitis
- 3.7.3.2. Urethritis
- 3.7.3.3. Pyelonephritis
- 3.8. Market Attractiveness Analysis: Indication
- 3.9. Global Urinary Tract Infection Testing Market Outlook: End Use
- 3.9.1. Introduction / Key Findings
- 3.9.2. Historical Market Size (US$ Mn ) and Volume (Units) Analysis By End Use, 2019-2023
- 3.9.3. Current Market Size (US$ Mn ) and Volume (Units) Forecast By End Use, 2024-2031
- 3.9.3.1. Hospitals
- 3.9.3.2. Nephropathy Clinics
- 3.9.3.3. Diagnostic Laboratories
- 3.9.3.4. others
- 3.10. Market Attractiveness Analysis: End Use
4. Global Urinary Tract Infection Testing Market Outlook: Region
- 4.1. Key Highlights
- 4.2. Historical Market Size (US$ Mn ) and Volume (Units) Analysis By Region, 2019-2023
- 4.3. Current Market Size (US$ Mn ) and Volume (Units) Forecast By Region, 2024-2031
- 4.3.1. North America
- 4.3.2. Europe
- 4.3.3. East Asia
- 4.3.4. South Asia and Oceania
- 4.3.5. Latin America
- 4.3.6. Middle East & Africa (MEA)
- 4.4. Market Attractiveness Analysis: Region
5. North America Urinary Tract Infection Testing Market Outlook: Historical (2019-2023) and Forecast (2024-2031)
- 5.1. Key Highlights
- 5.2. Pricing Analysis
- 5.3. Historical Market Size (US$ Mn ) and Volume (Units) Analysis By Market, 2019-2023
- 5.3.1. By Country
- 5.3.2. By Tests
- 5.3.3. By Tests Kits
- 5.3.4. By Indication
- 5.3.5. By End Use
- 5.4. Current Market Size (US$ Mn ) and Volume (Units) Forecast By Country, 2024-2031
- 5.4.1. U.S.
- 5.4.2. Canada
- 5.5. Current Market Size (US$ Mn ) and Volume (Units) Forecast By Tests, 2024-2031
- 5.5.1. Urinalysis
- 5.5.2. Urine Cultures
- 5.5.3. Susceptibility Testing
- 5.6. Current Market Size (US$ Mn ) and Volume (Units) Forecast By Tests Kits, 2024-2031
- 5.6.1. Home Test Kits
- 5.6.2. Laboratory Test Kits
- 5.7. Current Market Size (US$ Mn ) and Volume (Units) Forecast By Indication, 2024-2031
- 5.7.1. Cystitis
- 5.7.2. Urethritis
- 5.7.3. Pyelonephritis
- 5.8. Current Market Size (US$ Mn ) and Volume (Units) Forecast By End Use, 2024-2031
- 5.8.1. Hospitals
- 5.8.2. Nephropathy Clinics
- 5.8.3. Diagnostic Laboratories
- 5.8.4. others
- 5.9. Market Attractiveness Analysis
6. Europe Urinary Tract Infection Testing Market Outlook: Historical (2019-2023) and Forecast (2024-2031)
- 6.1. Key Highlights
- 6.2. Pricing Analysis
- 6.3. Historical Market Size (US$ Mn ) and Volume (Units) Analysis By Market, 2019-2023
- 6.3.1. By Country
- 6.3.2. By Tests
- 6.3.3. By Tests Kits
- 6.3.4. By Indication
- 6.3.5. By End Use
- 6.4. Current Market Size (US$ Mn ) and Volume (Units) Forecast By Country, 2024-2031
- 6.4.1. Germany
- 6.4.2. France
- 6.4.3. U.K.
- 6.4.4. Italy
- 6.4.5. Spain
- 6.4.6. Russia
- 6.4.7. Turkey
- 6.4.8. Rest of Europe
- 6.5. Current Market Size (US$ Mn ) and Volume (Units) Forecast By Tests, 2024-2031
- 6.5.1. Urinalysis
- 6.5.2. Urine Cultures
- 6.5.3. Susceptibility Testing
- 6.6. Current Market Size (US$ Mn ) and Volume (Units) Forecast By Tests Kits, 2024-2031
- 6.6.1. Home Test Kits
- 6.6.2. Laboratory Test Kits
- 6.7. Current Market Size (US$ Mn ) and Volume (Units) Forecast By Indication, 2024-2031
- 6.7.1. Cystitis
- 6.7.2. Urethritis
- 6.7.3. Pyelonephritis
- 6.8. Current Market Size (US$ Mn ) and Volume (Units) Forecast By End Use, 2024-2031
- 6.8.1. Hospitals
- 6.8.2. Nephropathy Clinics
- 6.8.3. Diagnostic Laboratories
- 6.8.4. others
- 6.9. Market Attractiveness Analysis
7. East Asia Urinary Tract Infection Testing Market Outlook: Historical (2019-2023) and Forecast (2024-2031)
- 7.1. Key Highlights
- 7.2. Pricing Analysis
- 7.3. Historical Market Size (US$ Mn ) and Volume (Units) Analysis By Market, 2019-2023
- 7.3.1. By Country
- 7.3.2. By Tests
- 7.3.3. By Tests Kits
- 7.3.4. By Indication
- 7.3.5. By End Use
- 7.4. Current Market Size (US$ Mn ) and Volume (Units) Forecast By Country, 2024-2031
- 7.4.1. China
- 7.4.2. Japan
- 7.4.3. South Korea
- 7.5. Current Market Size (US$ Mn ) and Volume (Units) Forecast By Tests, 2024-2031
- 7.5.1. Urinalysis
- 7.5.2. Urine Cultures
- 7.5.3. Susceptibility Testing
- 7.6. Current Market Size (US$ Mn ) and Volume (Units) Forecast By Tests Kits, 2024-2031
- 7.6.1. Home Test Kits
- 7.6.2. Laboratory Test Kits
- 7.7. Current Market Size (US$ Mn ) and Volume (Units) Forecast By Indication, 2024-2031
- 7.7.1. Cystitis
- 7.7.2. Urethritis
- 7.7.3. Pyelonephritis
- 7.8. Current Market Size (US$ Mn ) and Volume (Units) Forecast By End Use, 2024-2031
- 7.8.1. Hospitals
- 7.8.2. Nephropathy Clinics
- 7.8.3. Diagnostic Laboratories
- 7.8.4. others
- 7.9. Market Attractiveness Analysis
8. South Asia & Oceania Urinary Tract Infection Testing Market Outlook: Historical (2019-2023) and Forecast (2024-2031)
- 8.1. Key Highlights
- 8.2. Pricing Analysis
- 8.3. Historical Market Size (US$ Mn ) and Volume (Units) Analysis By Market, 2019-2023
- 8.3.1. By Country
- 8.3.2. By Tests
- 8.3.3. By Tests Kits
- 8.3.4. By Indication
- 8.3.5. By End Use
- 8.4. Current Market Size (US$ Mn ) and Volume (Units) Forecast By Country, 2024-2031
- 8.4.1. India
- 8.4.2. Southeast Asia
- 8.4.3. ANZ
- 8.4.4. Rest of South Asia & Oceania
- 8.5. Current Market Size (US$ Mn ) and Volume (Units) Forecast By Tests, 2024-2031
- 8.5.1. Urinalysis
- 8.5.2. Urine Cultures
- 8.5.3. Susceptibility Testing
- 8.6. Current Market Size (US$ Mn ) and Volume (Units) Forecast By Tests Kits, 2024-2031
- 8.6.1. Home Test Kits
- 8.6.2. Laboratory Test Kits
- 8.7. Current Market Size (US$ Mn ) and Volume (Units) Forecast By Indication, 2024-2031
- 8.7.1. Cystitis
- 8.7.2. Urethritis
- 8.7.3. Pyelonephritis
- 8.8. Current Market Size (US$ Mn ) and Volume (Units) Forecast By End Use, 2024-2031
- 8.8.1. Hospitals
- 8.8.2. Nephropathy Clinics
- 8.8.3. Diagnostic Laboratories
- 8.8.4. others
- 8.9. Market Attractiveness Analysis
9. Latin America Urinary Tract Infection Testing Market Outlook: Historical (2019-2023) and Forecast (2024-2031)
- 9.1. Key Highlights
- 9.2. Pricing Analysis
- 9.3. Historical Market Size (US$ Mn ) and Volume (Units) Analysis By Market, 2019-2023
- 9.3.1. By Country
- 9.3.2. By Tests
- 9.3.3. By Tests Kits
- 9.3.4. By Indication
- 9.3.5. By End Use
- 9.4. Current Market Size (US$ Mn ) and Volume (Units) Forecast By Country, 2024-2031
- 9.4.1. Brazil
- 9.4.2. Mexico
- 9.4.3. Rest of Latin America
- 9.5. Current Market Size (US$ Mn ) and Volume (Units) Forecast By Tests, 2024-2031
- 9.5.1. Urinalysis
- 9.5.2. Urine Cultures
- 9.5.3. Susceptibility Testing
- 9.6. Current Market Size (US$ Mn ) and Volume (Units) Forecast By Tests Kits, 2024-2031
- 9.6.1. Home Test Kits
- 9.6.2. Laboratory Test Kits
- 9.7. Current Market Size (US$ Mn ) and Volume (Units) Forecast By Indication, 2024-2031
- 9.7.1. Cystitis
- 9.7.2. Urethritis
- 9.7.3. Pyelonephritis
- 9.8. Current Market Size (US$ Mn ) and Volume (Units) Forecast By End Use, 2024-2031
- 9.8.1. Hospitals
- 9.8.2. Nephropathy Clinics
- 9.8.3. Diagnostic Laboratories
- 9.8.4. others
- 9.9. Market Attractiveness Analysis
10. Middle East & Africa Urinary Tract Infection Testing Market Outlook: Historical (2019-2023) and Forecast (2024-2031)
- 10.1. Key Highlights
- 10.2. Pricing Analysis
- 10.3. Historical Market Size (US$ Mn ) and Volume (Units) Analysis By Market, 2019-2023
- 10.3.1. By Country
- 10.3.2. By Tests
- 10.3.3. By Tests Kits
- 10.3.4. By Indication
- 10.3.5. By End Use
- 10.4. Current Market Size (US$ Mn ) and Volume (Units) Forecast By Country, 2024-2031
- 10.4.1. GCC
- 10.4.2. Egypt
- 10.4.3. South Africa
- 10.4.4. Northern Africa
- 10.4.5. Rest of Middle East & Africa
- 10.5. Current Market Size (US$ Mn ) and Volume (Units) Forecast By Tests, 2024-2031
- 10.5.1. Urinalysis
- 10.5.2. Urine Cultures
- 10.5.3. Susceptibility Testing
- 10.6. Current Market Size (US$ Mn ) and Volume (Units) Forecast By Tests Kits, 2024-2031
- 10.6.1. Home Test Kits
- 10.6.2. Laboratory Test Kits
- 10.7. Current Market Size (US$ Mn ) and Volume (Units) Forecast By Indication, 2024-2031
- 10.7.1. Cystitis
- 10.7.2. Urethritis
- 10.7.3. Pyelonephritis
- 10.8. Current Market Size (US$ Mn ) and Volume (Units) Forecast By End Use, 2024-2031
- 10.8.1. Hospitals
- 10.8.2. Nephropathy Clinics
- 10.8.3. Diagnostic Laboratories
- 10.8.4. others
- 10.9. Market Attractiveness Analysis
11. Competition Landscape
- 11.1. Market Share Analysis, 2024
- 11.2. Market Structure
- 11.2.1. Competition Intensity Mapping By Market
- 11.2.2. Competition Dashboard
- 11.2.3. Apparent Tests Capacity
- 11.3. Company Profiles (Details - Overview, Financials, Strategy, Recent Developments)
- 11.3.1. ACON Laboratories Inc.
- 11.3.1.1. Overview
- 11.3.1.2. Segments and Tests
- 11.3.1.3. Key Financials
- 11.3.1.4. Market Developments
- 11.3.1.5. Market Strategy
- 11.3.2. Cardinal Health Inc.
- 11.3.2.1. Overview
- 11.3.2.2. Segments and Tests
- 11.3.2.3. Key Financials
- 11.3.2.4. Market Developments
- 11.3.2.5. Market Strategy
- 11.3.3. Danaher Corporation
- 11.3.3.1. Overview
- 11.3.3.2. Segments and Tests
- 11.3.3.3. Key Financials
- 11.3.3.4. Market Developments
- 11.3.3.5. Market Strategy
- 11.3.4. SYSMEX CORPORATION
- 11.3.4.1. Overview
- 11.3.4.2. Segments and Tests
- 11.3.4.3. Key Financials
- 11.3.4.4. Market Developments
- 11.3.4.5. Market Strategy
- 11.3.5. Abbott Laboratories
- 11.3.5.1. Overview
- 11.3.5.2. Segments and Tests
- 11.3.5.3. Key Financials
- 11.3.5.4. Market Developments
- 11.3.5.5. Market Strategy
- 11.3.6. Bio-Rad Laboratories
- 11.3.6.1. Overview
- 11.3.6.2. Segments and Tests
- 11.3.6.3. Key Financials
- 11.3.6.4. Market Developments
- 11.3.6.5. Market Strategy
- 11.3.7. Roche AG
- 11.3.7.1. Overview
- 11.3.7.2. Segments and Tests
- 11.3.7.3. Key Financials
- 11.3.7.4. Market Developments
- 11.3.7.5. Market Strategy
- 11.3.8. LabCorp (Laboratory Corporation of America Holdings).
- 11.3.8.1. Overview
- 11.3.8.2. Segments and Tests
- 11.3.8.3. Key Financials
- 11.3.8.4. Market Developments
- 11.3.8.5. Market Strategy
- 11.3.9. Stryker Corporation
- 11.3.9.1. Overview
- 11.3.9.2. Segments and Tests
- 11.3.9.3. Key Financials
- 11.3.9.4. Market Developments
- 11.3.9.5. Market Strategy
- 11.3.10. Thermo Fisher Scientific, Inc.
- 11.3.10.1. Overview
- 11.3.10.2. Segments and Tests
- 11.3.10.3. Key Financials
- 11.3.10.4. Market Developments
- 11.3.10.5. Market Strategy
12. Appendix
- 12.1. Research Methodology
- 12.2. Research Assumptions
- 12.3. Acronyms and Abbreviations
